$CLPT News

ClearPoint Neuro Collaborates With SONOCARELAB To Tap Focused Ultrasound Market

ClearPoint Neuro, Inc. (CLPT) Q1 2026 Earnings Call Transcript

ClearPoint Neuro Q1 2026 Earnings Call Transcript

ClearPoint Neuro: Temporary Headwinds Don't Change The Long-Term Outlook

ClearPoint Neuro Announces FDA Clearance Of Velocity Alpha MR High Speed Surgical Drill System And First Clinical Use

ClearPoint Neuro Announces FDA Clearance Of Velocity Alpha MR High Speed Surgical Drill System And First Clinical Use

ClearPoint Neuro Receives Health Canada's Medical Device License For Its Neuro Navigation System

Why The ClearPoint Neuro (CLPT) Investment Story Is Shifting On Regulatory And Partnership Risks

Why The ClearPoint Neuro (CLPT) Story Is Shifting After New Partner And FDA Updates

ClearPoint Neuro Q4 Earnings Call Highlights

B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $20

ClearPoint Neuro shares are trading lower after the company reported mixed Q4 financial results and cut its FY26 guidance.

ClearPoint Neuro, Inc. Q4 2025 Earnings Call Summary

ClearPoint Neuro (CLPT) Earnings Call Transcript

ClearPoint Neuro, Inc. (CLPT) Reports Q4 Loss, Tops Revenue Estimates

ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Q4 2025 Revenue Beat Amid Widened Loss, Shares Fall

ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results

ClearPoint Neuro, Inc. (CLPT) Q4 2025 Earnings Call Transcript

ClearPoint Neuro Q4 EPS $(0.23) Misses $(0.20) Estimate, Sales $10.400M Beat $10.050M Estimate

ClearPoint Neuro Lowers FY2026 Sales Guidance from $54.000M-$60.000M to $52.000M-$56.000M